McClellan-Kirkpatrick Act

GPTKB entity

Statements (64)
Predicate Object
gptkbp:instanceOf legislation
gptkbp:addresses advertising of pharmaceuticals
gptkbp:amends gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
gptkbp:enactedBy gptkb:United_States_Congress
gptkbp:encourages post-market surveillance
innovation in drug development
collaboration in research
patient enrollment in trials
data sharing in research
transparency in drug approval
gptkbp:enhances FDA's_regulatory_framework
gptkbp:established Drug Efficacy Study Implementation
Drug_Approval_Advisory_Committees
New_Drug_Application_process
gptkbp:facilitates drug recalls
https://www.w3.org/2000/01/rdf-schema#label McClellan-Kirkpatrick Act
gptkbp:impact public health policy
clinical trial design
medical device regulations
drug pricing policies
drug approval timelines
drug marketing practices
drug distribution practices
FDA_authority
gptkbp:influences pharmaceutical regulations
clinical research standards
healthcare_legislation
gptkbp:involves regulatory compliance
pharmaceutical companies
stakeholder engagement
healthcare_professionals
clinical trial participants
gptkbp:leads better patient outcomes
improved healthcare outcomes
enhanced drug monitoring
improved drug efficacy
increased accountability in drug approval
increased drug research
gptkbp:mandates safety monitoring
safety assessments
risk-benefit analysis
safety labeling changes
gptkbp:promotes patient safety
healthcare quality
evidence-based medicine
drug safety
gptkbp:purpose to improve the safety and efficacy of drugs
gptkbp:relatedTo drug approval process
gptkbp:requires adverse event reporting
post-marketing studies
safety data collection
clinical trials for drug approval
ethics review for trials
informed consent for trials
labeling of drugs
gptkbp:signature President_John_F._Kennedy
gptkbp:supports consumer protection
patient advocacy
public awareness campaigns
public health initiatives
research funding
scientific integrity
healthcare_research
gptkbp:yearEstablished 1966